PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells

Cardiovascular Research

Volumn 92, Issue 3, 2011, Pages 484-493

  Zhang, Li Li ^a   Gao, Chang Yue ^a   Fang, Chuan Qin ^a   Wang, Yan Jiang ^a   Gao, Dong ^a   Yao, Guo En ^a   Xiang, Jing ^a   Wang, Jing Zhou ^a   Li, Jing Cheng ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Intimal hyperplasia; Peroxisome proliferator activated receptor ; Toll like receptor 4; Vascular smooth muscle cell

Indexed keywords

CYTOKINE; ERITORAN; LIPOPOLYSACCHARIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLATELET DERIVED GROWTH FACTOR; ROSIGLITAZONE; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAROTID ARTERY DISEASE; CELL MIGRATION; CELL PROLIFERATION; GENE OVEREXPRESSION; GENE SILENCING; HYPERPLASIA; INFLAMMATION; INTIMAL HYPERPLASIA; MALE; MOUSE; MUSCLE CELL; NEOINTIMA; NONHUMAN; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

ANIMALS; CAROTID ARTERY INJURIES; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DISACCHARIDES; DISEASE MODELS, ANIMAL; HYPERPLASIA; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PLATELET-DERIVED GROWTH FACTOR; PPAR GAMMA; RNA INTERFERENCE; SUGAR PHOSPHATES; THIAZOLIDINEDIONES; TOLL-LIKE RECEPTOR 4; TRANSFECTION; TUNICA INTIMA;

EID: 81055143970     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr238     Document Type: Article

References (37)

1. Zhang LN, Parkinson JF, Haskell C, Wang YX. Mechanisms of intimal hyperplasia learned from a murine carotid artery ligation model. Curr Vasc Pharmacol 2008;6: 37-43.
2. Tsai S, Butler J, Rafii S, Liu B, Kent KC. The role of progenitor cells in the development of intimal hyperplasia. J Vasc Surg 2009;49:502-510.
3. Xiong C, Mou Y, Zhang J, Fu M, Chen YE, Akinbami MA et al. Impaired expression of PPARg protein contributes to the exaggerated growth of vascular smooth muscle cells in spontaneously hypertensive rats. Life Sci 2005;77:3037-3048. (Pubitemid 41423741)
4. Law RE, Goetze S, Xi XP, Jackson S, Kawano Y, Demer L et al. Expression and function of PPARg in rat and human vascular smooth muscle cells. Circulation 2000;101: 1311-1318. (Pubitemid 30158620)
5. Hattori Y, Akimoto K, Kasai K. The effects of thiazolidinediones on vascular smooth muscle cell activation by angiotensin II. Biochem Biophys Res Commun 2000;273: 1144-1149. (Pubitemid 30481093)
6. Marx N, Schonbeck U, Lazar MA, Libby P, Plutzky J. Peroxisome proliferator-activated receptor g activators inhibit gene expression and migration in human vascular smooth muscle cells. Circ Res 1998;83:1097-1103. (Pubitemid 28533518)
7. Phillips JW, Barringhaus KG, Sanders JM, Yang Z, Chen M, Hesselbacher S et al. Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes. Circulation 2003;108:1994-1999. (Pubitemid 37296545)
8. Desouza CV, Murthy SN, Diez J, Dunne B, Matta AS, Fonseca VA et al. Differential effects of peroxisome proliferator activator receptor-a and g ligands on intimal hyperplasia after balloon catheter-induced vascular injury in Zucker rats. J Cardiovasc Pharmacol Ther 2003;8:297-305. (Pubitemid 38045081)
9. Sidhu JS, Kaposzta Z, Markus HS, Kaski JC. Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus. Arterioscler Thromb Vasc Biol 2004;24:930-934. (Pubitemid 38620874)
10. Pasceri V, Wu HD, Willerson JT, Yeh ET. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-g activators. Circulation 2000;101:235-238. (Pubitemid 30054148)
11. Dasu MR, Devaraj S, Zhao L, Hwang DH, Jialal I. High glucose induces Toll-like receptor expression in human monocytes: mechanism of activation. Diabetes 2008;57: 3090-3098.
12. de Graaf R, Kloppenburg G, Kitslaar PJ, Bruggeman CA, Stassen F. Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4. Microbes Infect 2006;8:1859-1865. (Pubitemid 44128888)
13. Hollestelle SC, De Vries MR, Van Keulen JK, Schoneveld AH, Vink A, Strijder CF et al. Toll-like receptor 4 is involved in outward arterial remodeling. Circulation 2004;109: 393-398. (Pubitemid 38139309)
14. Lin FY, Chen YH, Tasi JS, Chen JW, Yang TL, Wang HJ et al. Endotoxin induces Tolllike receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways. Arterioscler Thromb Vasc Biol 2006;26:2630-2637.
15. Lindner V, Fingerle J, Reidy MA. Mouse model of arterial injury. Circ Res 1993;73: 792-796. (Pubitemid 23306123)
16. Xu X, Ha CH, Wong C, Wang W, Hausser A, Pfizenmaier K et al. Angiotensin II stimulates protein kinase D-dependent histone deacetylase 5 phosphorylation and nuclear export leading to vascular smooth muscle cell hypertrophy. Arterioscler Thromb Vasc Biol 2007;27:2355-2362. (Pubitemid 350203950)
17. Millette E, Rauch BH, Defawe O, Kenagy RD, Daum G, Clowes AW. Platelet-derived growth factor-BB-induced human smooth muscle cell proliferation depends on basic FGF release and FGFR-1 activation. Circ Res 2005;96:172-179. (Pubitemid 40209364)
18. Zhang L, Xie P, Wang J, Yang Q, Fang C, Zhou S et al. Impaired peroxisome proliferator-activated receptor-g contributes to phenotypic modulation of vascular smooth muscle cells during hypertension. J Biol Chem 2010;285:13666-13677.
19. Yang X, Coriolan D, Murthy V, Schultz K, Golenbock DT, Beasley D. Proinflammatory phenotype of vascular smooth muscle cells: role of efficient Toll-like receptor 4 signaling. Am J Physiol Heart Circ Physiol 2005;289:H1069-H1076. (Pubitemid 41208948)
20. Owens GK, Kumar MS,Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 2004;84:767-801. (Pubitemid 38823766)
21. Hlawaty H, Suffee N, Sutton A, Oudar O, Haddad O, Ollivier V et al. Low molecular weight fucoidan prevents intimal hyperplasia in rat injured thoracic aorta through the modulation of matrix metalloproteinase-2 expression. Biochem Pharmacol 2011;81: 233-243.
22. Takata Y, Kitami Y, Yang ZH, Nakamura M, Okura T, Hiwada K. Vascular inflammation is negatively autoregulated by interaction between CCAAT/enhancer-binding protein-d and peroxisome proliferator-activated receptor-g. Circ Res 2002;91: 427-433. (Pubitemid 35034211)
23. Wakino S, Kintscher U, Kim S, Yin F, Hsueh WA, Law RE. Peroxisome proliferatoractivated receptor g ligands inhibit retinoblastoma phosphorylation and G1S transition in vascular smooth muscle cells. J Biol Chem 2000;275:22435-22441. (Pubitemid 30621831)
24. Ogawa D, Nomiyama T, Nakamachi T, Heywood EB, Stone JF, Berger JP et al. Activation of peroxisome proliferator-activated receptor g suppresses telomerase activity in vascular smooth muscle cells. Circ Res 2006;98:e50-e59.
25. Wang D, Liu Z, Li Q, Karpurapu M, Kundumani-Sridharan V, Cao H et al. An essential role for gp130 in neointima formation following arterial injury. Circ Res 2007;100: 807-816. (Pubitemid 46555685)
26. Takaoka M, Uemura S, Kawata H, Imagawa K, Takeda Y, Nakatani K et al. Inflammatory response to acute myocardial infarction augments neointimal hyperplasia after vascular injury in a remote artery. Arterioscler Thromb Vasc Biol 2006;26:2083-2089. (Pubitemid 44253792)
27. Epstein H, Grad E, Golomb M, Koroukhov N, Edelman ER, Golomb G et al. Innate immunity has a dual effect on vascular healing: suppression and aggravation of neointimal formation and remodeling post-endotoxin challenge. Atherosclerosis 2008;199:41-46.
28. Shimamoto A, Chong AJ, Yada M, Shomura S, Takayama H, Fleisig AJ et al. Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation 2006;114:I-270-I-274. (Pubitemid 44297162)
29. Guha M, Mackman N. LPS induction of gene expression in human monocytes. Cell Signal 2001;13:85-94. (Pubitemid 32222977)
30. Kol A, Sukhova GK, Lichtman AH, Libby P. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-a and matrix metalloproteinase expression. Circulation 1998;98:300-307. (Pubitemid 28348051)
31. Scirocco A, Matarrese P, Petitta C, Cicenia A, Ascione B, Mannironi C et al. Exposure of Toll-like receptors 4 to bacterial lipopolysaccharide (LPS) impairs human colonic smooth muscle cell function. J Cell Physiol 2010;223:442-450.
32. Thyberg J, Blomgren K, Roy J, Tran PK, Hedin U. Phenotypic modulation of smooth muscle cells after arterial injury is associated with changes in the distribution of laminin and fibronectin. J Histochem Cytochem 1997;45:837-846. (Pubitemid 27248799)
33. Chajara A, Raoudi M, Delpech B, Leroy M, Basuyau JP, Levesque H. Increased hyaluronan and hyaluronidase production and hyaluronan degradation in injured aorta of insulin-resistant rats. Arterioscler Thromb Vasc Biol 2000;20:1480-1487. (Pubitemid 30353877)
34. Ji Y, Liu J, Wang Z, Liu N, Gou W. PPARg agonist, rosiglitazone, regulates angiotensin II-induced vascular inflammation through the TLR4-dependent signaling pathway. Lab Invest 2009;89:887-902.
35. Dasu MR, Park S, Devaraj S, Jialal I. Pioglitazone inhibits Toll-like receptor expression and activity in human monocytes and db/db mice. Endocrinology 2009;150:3457-3464.
36. Necela BM, Su W, Thompson EA. Toll-like receptor 4 mediates cross-talk between peroxisome proliferator-activated receptor g and nuclear factor-kB in macrophages. Immunology 2008;125:344-358.
37. Deng DX, Spin JM, Tsalenko A, Vailaya A, Ben-Dor A, Yakhini Z et al. Molecular signatures determining coronary artery and saphenous vein smooth muscle cell phenotypes: distinct responses to stimuli. Arterioscler Thromb Vasc Biol 2006;26:1058-1065. (Pubitemid 43732112)